Cargando…

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus

Drug combinations are synergistic when their combined efficacy exceeds the sum of the individual actions, but they rarely include ineffective drugs that become effective only in combination. We identified several “enabling pairs” of neutralizing and non-neutralizing anti-ebolavirus monoclonal antibo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howell, Katie A., Brannan, Jennifer M., Bryan, Christopher, McNeal, Andrew, Davidson, Edgar, Turner, Hannah L., Vu, Hong, Shulenin, Sergey, He, Shihua, Kuehne, Ana, Herbert, Andrew S., Qiu, Xiangguo, Doranz, Benjamin J., Holtsberg, Frederick W., Ward, Andrew B., Dye, John M., Aman, M. Javad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082427/ https://www.ncbi.nlm.nih.gov/pubmed/28402862 http://dx.doi.org/10.1016/j.celrep.2017.03.049

Ejemplares similares

Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
por: Brannan, Jennifer M., et al.
Publicado: (2019)

A Shared Structural Solution for Neutralizing Ebolaviruses
por: Dias, João M., et al.
Publicado: (2011)

Structural Basis of Broad Ebolavirus Neutralization by a Human Survivor Antibody
por: West, Brandyn R., et al.
Publicado: (2019)

Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
por: Gilchuk, Pavlo, et al.
Publicado: (2020)

Structural Basis for Differential Neutralization of Ebolaviruses
por: Bale, Shridhar, et al.
Publicado: (2012)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018)

Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
por: Murin, Charles D., et al.
Publicado: (2021)

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
por: Murin, Charles D., et al.
Publicado: (2022)

Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
por: Chen, Elaine C., et al.
Publicado: (2023)

Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs
por: Adhikari, Rajan P., et al.
Publicado: (2015)

Correction: Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs
por: Adhikari, Rajan P., et al.
Publicado: (2015)

Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
por: Gilchuk, Pavlo, et al.
Publicado: (2021)

Characterization of Sudan Ebolavirus infection in ferrets
por: Kroeker, Andrea, et al.
Publicado: (2017)

Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
por: Howell, Katie A., et al.
Publicado: (2016)

Niemann-Pick C1 Is Essential for Ebolavirus Replication and Pathogenesis In Vivo
por: Herbert, Andrew S., et al.
Publicado: (2015)

Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
por: Gilchuk, Pavlo, et al.
Publicado: (2018)

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
por: King, Liam B., et al.
Publicado: (2019)

Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles
por: Warfield, Kelly L., et al.
Publicado: (2015)

Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors
por: Bramble, Matthew S, et al.
Publicado: (2018)

Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralization
por: Kailasan, Shweta, et al.
Publicado: (2022)

Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses
por: Bounds, Callie E., et al.
Publicado: (2015)

Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus
por: DeMers, Haley L., et al.
Publicado: (2020)

Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
por: West, Brandyn R., et al.
Publicado: (2018)

TBA(225), a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens
por: Venkatasubramaniam, Arundhathi, et al.
Publicado: (2019)

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV
por: Phelps, Amanda L., et al.
Publicado: (2021)

In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
por: Patel, Ami, et al.
Publicado: (2018)

Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses
por: Stonier, Spencer W., et al.
Publicado: (2017)

Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats
por: Ng, Melinda, et al.
Publicado: (2015)

Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses
por: Swetha, Rayapadi G., et al.
Publicado: (2016)

Phylogenetic Analysis of Guinea 2014 EBOV Ebolavirus Outbreak
por: Dudas, Gytis, et al.
Publicado: (2014)

Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
por: Lubow, Jay, et al.
Publicado: (2023)

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)
por: Dye, John M., et al.
Publicado: (2016)

Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease
por: Luczkowiak, Joanna, et al.
Publicado: (2018)

Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
por: Yuan, Tom Z., et al.
Publicado: (2021)

Ebolavirus comparative genomics
por: Jun, Se-Ran, et al.
Publicado: (2015)

Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors
por: Sobarzo, Ariel, et al.
Publicado: (2016)

Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications
por: Whitbeck, J. Charles, et al.
Publicado: (2020)

Virological diagnosis of Ebolavirus infection
por: Smith, D. W., et al.
Publicado: (2015)

Assembly and Budding of Ebolavirus
por: Noda, Takeshi, et al.
Publicado: (2006)

Ebolavirus and Other Filoviruses
por: Leroy, E., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_20mqgnjmnpn1nccrdj80f2nktr